- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 0.3% over the previous month of $321.51m and a drop of 95.9% when compared with the last 12-month average, which stood at $7.88bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $240m. At the country level, the US topped the list in terms of deal value at $240m.
In terms of volumes, Europe emerged as the top region for medical devices industry M&A deals globally, followed by North America and then Asia-Pacific.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The top country in terms of M&A deals activity in March 2022 was the US with 11 deals, followed by the UK with four and Japan with three.
In 2022, as of March, medical devices M&A deals worth $7.12bn were announced globally, marking an increase of 73.9% year on year.
medical devices industry M&A deals in March 2022: Top deals
The top five M&A deals accounted for 100% of the overall value during March 2022.
The combined value of the top five medical devices M&A deals stood at $320.55m, against the overall value of $320.6m recorded for the month.
The top five medical devices industry M&A deals of March 2022 tracked by GlobalData were:
1) Fresenius Kabi $240m acquisition deal with Ivenix
2) The $24.35m acquisition of LDPath by SourceBio International
3) BioKey and ImmunoPrecise Netherlands $21.94m acquisition deal with BioClue and BioStrand
4) The $21.06m acquisition of Sinusafe Medical by Bold Capital Enterprises
5) SD Biosensor $13.2m acquisition deal with bestbion dx